BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25927427)

  • 21. Ethnic differences in the expression of Epstein-Barr virus latent membrane protein-1 mutations in nasopharyngeal carcinoma.
    D'Addario M; Chauvin P
    Mutat Res; 2000 Dec; 457(1-2):69-78. PubMed ID: 11106799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
    Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The LMP1 gene isolated from Russian nasopharyngeal carcinoma has no 30-bp deletion.
    Hahn P; Novikova E; Scherback L; Janik C; Pavlish O; Arkhipov V; Nicholls J; Müller-Lantzsch N; Gurtsevitch V; Grässer FA
    Int J Cancer; 2001 Mar; 91(6):815-21. PubMed ID: 11275985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.
    Yu PH; Chou SF; Chen CL; Hung H; Lai CY; Yang PM; Jeng YM; Liaw SF; Kuo HH; Hsu HC; Chen JY; Wang WB
    PLoS One; 2013; 8(12):e82254. PubMed ID: 24340011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carboxy-terminal sequence variation of LMP1 gene in Epstein-Barr-virus-associated mononucleosis and tumors from Serbian patients.
    Banko A; Lazarevic I; Cupic M; Stevanovic G; Boricic I; Jovanovic T
    J Med Virol; 2012 Apr; 84(4):632-42. PubMed ID: 22337303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of EBV-LMP1 gene mutation in plasma of patients with nasopharyngeal carcinoma in Chongqing].
    Yang Y; Wang Y; Qian D; He Y; Hong S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Feb; 22(4):153-6. PubMed ID: 18476617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-barr virus latent membrane protein 1 polymorphism in nasopharyngeal carcinoma and other oral cavity tumors in Russia.
    Senyuta N; Yakovleva L; Goncharova E; Scherback L; Diduk S; Smirnova K; Maksimovich D; Gurtsevitch V
    J Med Virol; 2014 Feb; 86(2):290-300. PubMed ID: 24009107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis.
    Li J; Zhang Y; Sun L; Liu S; Zhao M; Luo B
    Microbiol Spectr; 2022 Jun; 10(3):e0000622. PubMed ID: 35674441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma Progression.
    Banko AV; Lazarevic IB; Folic MM; Djukic VB; Cirkovic AM; Karalic DZ; Cupic MD; Jovanovic TP
    PLoS One; 2016; 11(4):e0153498. PubMed ID: 27071030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Dawson CW; Young LS; Ko CW; Hau PM; Lo KW
    J Pathol; 2015 Oct; 237(2):238-48. PubMed ID: 26096068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repression of DERL3 via DNA methylation by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
    Kondo S; Okabe A; Nakagawa T; Matsusaka K; Fukuyo M; Rahmutulla B; Dochi H; Mizokami H; Kitagawa Y; Kurokawa T; Mima M; Endo K; Sugimoto H; Wakisaka N; Misawa K; Yoshizaki T; Kaneda A
    Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166598. PubMed ID: 36372158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Tabata YHibi S; Teramura T; Kuriyama K; Yagi T; Todo S; Sawada T; Imashuku S
    Leuk Lymphoma; 2000 Jul; 38(3-4):373-80. PubMed ID: 10830744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The LMP1 oncogene sequence variations in patients with oral tumours associated or not associated with the Epstein Barr].
    Gurtsevitch VE; Iakovleva LS; Shcherbak LN; Goncharova EV; Smirnova KV; Diduk SV; Kondratova VN; Maksimovich DM; Lichtenstein AV; Seniuta NB
    Mol Biol (Mosk); 2013; 47(6):987-95. PubMed ID: 25509860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma.
    Guo L; Tang M; Yang L; Xiao L; Bode AM; Li L; Dong Z; Cao Y
    Int J Mol Med; 2012 Apr; 29(4):574-80. PubMed ID: 22266808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma.
    Kondo S; Wakisaka N; Schell MJ; Horikawa T; Sheen TS; Sato H; Furukawa M; Pagano JS; Yoshizaki T
    Int J Cancer; 2005 Jun; 115(3):368-76. PubMed ID: 15688379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.
    Nguyen-Van D; Ernberg I; Phan-Thi Phi P; Tran-Thi C; Hu L
    Virus Genes; 2008 Oct; 37(2):273-81. PubMed ID: 18663567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Epstein-Barr virus strains and LMP1-deletion variants in Portugal.
    Neves M; Marinho-Dias J; Ribeiro J; Esteves M; Maltez E; Baldaque I; Breda E; Monteiro E; Medeiros R; Sousa H
    J Med Virol; 2015 Aug; 87(8):1382-8. PubMed ID: 25879824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EBV‑LMP1 is involved in vasculogenic mimicry formation via VEGFA/VEGFR1 signaling in nasopharyngeal carcinoma.
    Xu S; Bai J; Zhuan Z; Li B; Zhang Z; Wu X; Luo X; Yang L
    Oncol Rep; 2018 Jul; 40(1):377-384. PubMed ID: 29749553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Clinical Significance of IGF-1R and Relationship with Epstein-Barr Virus Markers: LMP1 and EBERs in Tunisian Patients with Nasopharyngeal Carcinoma.
    Baizig NM; Wided BA; Amine OE; Gritli S; ElMay M
    Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):1011-1019. PubMed ID: 32468823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.